Yes, RNA transcripts can guide treatment strategies. By analyzing the transcriptome of a tumor, clinicians can identify specific molecular targets for therapy. For instance, the detection of the HER2 transcript in breast cancer can lead to the use of targeted therapies like trastuzumab. Additionally, RNA interference (RNAi) and antisense oligonucleotides are being explored as therapeutic approaches to silence oncogenic RNA transcripts.
